Zdrowie i gospodarka · 11/04/2014

FDA Amends Advisory Committee Regulations to Reflect Changes in Reproductive Health Drugs Committee

The FDA is updating the regulations governing its advisory committees to align with changes made to the charter of the Advisory Committee for Reproductive Health Drugs, formerly known as the Bone, Reproductive and Urologic Drugs Advisory Committee.